Monitoring of WT1-specific cytotoxic T-lymphocytes after allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Morita, Y
Heike, Y
Kawakami, M
Miura, O
Mori, S
Tanosaki, R
Fukuda, T
Kim, S
Tobinai, K
Takaue, Y
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [1] Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation
    Morita, Yuriko
    Heike, Yuji
    Kawakami, Mami
    Miura, Osamu
    Nakatsuka, Shin-Ichi
    Ebisawa, Michiko
    Mori, Shin-Ichiro
    Tanosaki, Ryuji
    Fukuda, Takahiro
    Kim, Sung-Won
    Tobinai, Kensei
    Takaue, Yoichi
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (06) : 1360 - 1367
  • [2] Antilung cancer effect of WT1-specific cytotoxic T lymphocytes
    Makita, M
    Hiraki, A
    Azuma, T
    Tsuboi, A
    Oka, Y
    Sugiyama, H
    Fujita, S
    Tanimoto, M
    Harada, M
    Yasukawa, M
    CLINICAL CANCER RESEARCH, 2002, 8 (08) : 2626 - 2631
  • [3] WT1-specific T cell responses are frequent after allogeneic stem cell transplantation for acute and chronic myeloid leukemia.
    Gentilini, C
    Hilbers, U
    Ganepola, S
    Scheibenbogen, C
    Freyberg, K
    Niederwieser, DW
    Thiel, E
    Uharek, L
    BLOOD, 2005, 106 (11) : 178A - 178A
  • [4] Follow-up of WT1-specific cytotoxic T lymphocytes (CTL) with tetramer-based analysis after allogeneic stem cell transplantation (SCT) in patients with renal cell carcinoma (RCC).
    Morita, Y
    Hosokawa, M
    Heike, Y
    Sasaki, T
    Ebisawa, M
    Mori, S
    Tanosaki, R
    Kami, M
    Nosaka, K
    Ohnishi, M
    Miura, O
    Tobinai, K
    Takaue, Y
    BLOOD, 2004, 104 (11) : 584A - 584A
  • [5] High frequency of circulating functional WT1-specific CD8 T-cells in patients with myeloid malignancies after allogeneic haematopoietic stem cell transplantation
    Fuji, S.
    Fischer, J.
    Kapp, M.
    Bumm, T.
    Baumeister, E.
    Kashiwagi-Fuji, H.
    Dagvadorj, N.
    Rammensee, H.
    Stevanovic, S.
    Einsele, H.
    Huenig, T.
    Grigoleit, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S409 - S409
  • [6] Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation
    Jiang, Zhonghui
    Fan, Zhiping
    Zhang, Tian
    Lin, Ren
    Xu, Hui
    Xu, Na
    Huang, Fen
    Chi, Peiru
    Ou, Xueying
    Wang, Zhixiang
    Liu, Hui
    Zhao, Ke
    Jiang, Ling
    Yu, Sijian
    Sun, Jing
    Liu, Qifa
    Xuan, Li
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1393 - 1401
  • [7] Ex vivo generation of donor-derived WT1-specific cytotoxic T-cells able to lyse patient's leukaemia blasts for adoptive immunotherapy after allogeneic haematopoietic stem cell transplantation
    Turin, I.
    Lisini, D.
    Montini, E.
    Caliogna, L.
    Moretta, A.
    Bonetti, F.
    Zavras, N.
    Grecchi, I.
    Zecca, M.
    Maccario, R.
    Montagna, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S320 - S320
  • [8] WT1-specific T-cells as a therapeutic tool for cancer immunotherapy after stem cell transplantation
    Weber, G.
    Kuci, S.
    Karbach, J.
    Willasch, A. M.
    Kreyenberg, H.
    Klingebiel, T.
    Wels, W. S.
    Jaeger, E.
    Bader, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S300 - S301
  • [9] WT1-SPECIFIC CYTOTOXIC T LYMPHOCYTES INDUCED BY ACTIVATED B CELLS AS APC
    Yun, S.
    Baek, K.
    Shin, H.
    Kang, H.
    CYTOTHERAPY, 2019, 21 (05) : S32 - S32
  • [10] WT1-specific CD8+ T lymphocytes may participate in the elimination of acute lymphoblastic leukemia following allogeneic stem cell transplantation.
    Rezvani, Katayoun
    Yong, Agnes
    Mielke, Stephan
    Savani, Bipin N.
    Price, David A.
    Gostick, Emma
    Douek, Daniel C.
    Barrett, A. John
    BLOOD, 2006, 108 (11) : 1051A - 1051A
12345